-
Mashup Score: 0
The program gives individuals a look into the laboratory & provides insight to researchers from our community’s perspective
Source: www.jeffersonhealth.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1Focus | Innovative Cancer Care | Elekta - 3 month(s) ago
Explore cutting-edge cancer treatment and healthcare innovations in Focus, Elekta’s Online Magazine. Stay informed with the latest articles. Discover more.
Source: www.elekta.comCategories: General Medicine News, Oncologists1Tweet-
RT @Elekta: @KimmelCancerCtr @uktuebingen @KoneruMd ➡️ https://t.co/rGqNjvRDSq https://t.co/BaPKEXrZe5
-
-
Mashup Score: 1
Lindsay Wilde, MD, Thomas Jefferson University and Joanna S. Yi, MD, Baylor College of Medicine/Texas Children’s
Source: ash.confex.comCategories: General Medicine News, Oncologists1Tweet-
#ASH24: Starting at 4 p.m. PT, Dr. Lindsay Wilde is co-moderating an oral abstract session on clinical trials in pediatric and young adult patients with acute lymphoblastic leukemias (ALL): https://t.co/G1Z5DzCWNN https://t.co/YvjhckiRbp
-
-
Mashup Score: 11
Program: Oral and Poster Abstracts Type: Oral Session: 625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: When Old Meets New in T Cell Lymphomas Hematology Disease Topics & Pathways: Research, Clinical trials, Clinical Research, Patient-reported outcomes Martine Bagot, MD, PhD 1 *, Youn H. Kim, MD 2, Caroline Ram-Wolff, MD 1 *, Stéphane Dalle, MD, PhD 3 *, Neha Mehta-Shah, MD 4, Auris O Huen, MD, PharmD 5 *, Brian Poligone, MD, PhD 6 *, Pier Luigi Zinzani, MD, PhD 7, Larisa J
Source: ash.confex.comCategories: General Medicine News, Oncologists1Tweet-
#ASH24: Dr. Pierluigi Porcu is reporting quality of life data from the TELLOMAK trial of lacutamab in patients with relapsed/refractory cutaneous T cell lymphoma during an oral abstract session this morning: https://t.co/nElVCmc5Vp https://t.co/FCzMuQk68x
-
-
Mashup Score: 166th ASH Annual Meeting: Blood Drop: Translational Research Training in Hematology (TRTH) Program - 3 month(s) ago
Sara E. Meyer, PhD, Thomas Jefferson University, Sidney Kimmel Comprehensive Can cer Center Meyer: CellCentric: Research Funding. Learn about what the ASH-EHA Translational Research Training in Hematology (TRTH) Program has to offer through an awardees experiences, research/project, and career opportunities. It is intended for trainees and junior faculty engaged in laboratory-based translational and basic science research. Trainees and faculty holding MDs, MD/PhDs, biomedical PhDs, or pharmacy PharmDs
Source: ash.confex.comCategories: General Medicine News, Oncologists1Tweet-
#ASH24: Heading to ASH-a-Palooza this afternoon? Join Dr. Sara Meyer (@SaraMeyerLab) for a Blood Drop session 🩸 at either 1:30 or 1:50 p.m. to learn about the ASH-EHA Translational Research Training in Hematology (TRTH) Program! 🔗 https://t.co/aQtLWnaxEt https://t.co/gCYQJ99nY9
-
-
Mashup Score: 6
Further optimizing a PROTAC that targets MDM2 may lead to human clinical trials among patients with cancer harboring p53 mutations.
Source: www.cancernetwork.comCategories: General Medicine News, Oncologists1Tweet-
#ResearchWednesday: Dr. Chris Eischen talked to @CancerNetwrk about her work focusing on the development of a novel precision therapy for patients with p53-mutated cancer. https://t.co/6AH8mKX34R
-
-
Mashup Score: 0Breast Cancer Symposium | Jefferson Health - 4 month(s) ago
Join Jefferson’s top breast care experts as they share the latest advances in clinical treatments, research and the future of breast cancer.
Source: www.jeffersonhealth.orgCategories: General Medicine News, Oncologists1Tweet-
Join us for Survive and Thrive: Empowering Voices in Breast Cancer, a symposium for patients & survivors. Top experts will be addressing side effects of #breastcancer and treatment, risk reduction, and nutrition, & answering your questions. Register: https://t.co/380ucqkwuv #bcsm https://t.co/zio33NBtVI
-
-
Mashup Score: 1Cannabis in Cancer: What Oncologists and Patients Should Know - 5 month(s) ago
Many people with cancer are interested in using cannabis for symptom management, but few talk to their doctor about it. ASCO guidelines suggest making it a routine conversation.
Source: www.medscape.comCategories: General Medicine News, Oncologists1Tweet-
Cancer patients often use cannabis to manage symptoms without speaking to their doc first & oncologists may be hesitant to broach the topic. Our Dr. @BrookeWorster spoke to @medscape about how oncologists can discuss the topic with their patients. https://t.co/GQiukaCX91
-
-
Mashup Score: 2Coping With Metastatic Breast Cancer as a Young Adult - 5 month(s) ago
Diagnosed with stage IV breast cancer at age 25, Lourdes Monje is keeping their cancer in check by participating in a clinical trial.
Source: cancerprogressreport.aacr.orgCategories: General Medicine News, Oncologists1Tweet-
Lourdes was diagnosed with metastatic (stage IV) breast cancer at the age of 25 & is now participating in one of our clinical trials. Their story was featured in the @AACR's #CancerProgressReport 2024: https://t.co/hv3u934MQo #BreastCancerAwarenessMonth #bcsm #MBC @HafezMaria
-
-
Mashup Score: 8Party with a Purpose Supports Geriatric Oncology Research - 5 month(s) ago
Andrew Chapman and Kuang-Yi Wen of Thomas Jefferson University were named scientific awardees for their work in geriatric oncology research.
Source: www.aacr.orgCategories: General Medicine News, Oncologists1Tweet-
The Friends of the @AACRFoundation's Party with a Purpose is honoring Drs. @andrewchap361 & Kuang-Yi Wen at this year's gala, which will benefit #gerionc research. @AACR spoke with them about their work to improve care for older adults with cancer ➡️ https://t.co/KHN0OCBd3b https://t.co/fL6zOSOqyo
-
The Community Learning and Experience About Research (CLEAR) program pairs community members with our researchers, giving them a look into the lab & providing insight to researchers from the community perspective. Hear from some of our CLEAR participants: https://t.co/IV0W6yX7dd